Stockreport

Enable Injections and Serina Therapeutics Announce Agreement to Develop SER-252 in Combination with enFuse® for Advanced Parkinson's Disease [Yahoo! Finance]

Serina Therapeutics, Inc.  (SER) 
PDF and manufacturing the enFuse ® wearable drug delivery platform and Serina Therapeutics (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company advancing [Read more]